TotalMarketCap

Immunocore

IMCRNasdaq United KingdomHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$1.468 B

$28.51 -2.48%

Close of 6 Nov 2026

As of 6 Nov 2026, Immunocore (IMCR) has a market capitalization of $1.47B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$400.0M

#2002 by revenue

Earnings

-$35.5M

Loss-making

Shares outstanding

51,681,376

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #40NovavaxNVAX$1.61B
  2. #41Lycia TherapeuticsLYCA$1.50B
  3. #42ImmunocoreIMCR$1.47B
  4. #43Taysha Gene TherapiesTSHA$1.35B
  5. #44Inhibrx BiosciencesINBX$1.18B

What if Immunocore were worth as much as…

Open the what-if tool →

Gold $28.2T

$548,303.54

Per share 19,235× higher

Bitcoin $1.53T

$29,667.75

Per share 1,041× higher

Apple $5.02T

$97,396.45

Per share 3,417× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Immunocore are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.